{
  "meta": {
    "data_length": 1,
    "message": "Therapy id tx:ncit:C49085 retrieved successfully",
    "request_url": "http://api.moalmanac.org/therapies?therapy_id=tx%3Ancit%3AC49085",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.001652,
    "timestamp_received": "2026-09-25T00:13:01.894296+00:00Z",
    "timestamp_returned": "2026-09-25T00:13:01.895948+00:00Z",
    "trace_id": "fe541650-09db-48d6-a7a1-b5a3956b3ffc"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-08-02"
  },
  "data": [
    {
      "id": "tx:ncit:C49085",
      "conceptType": "Therapy",
      "name": "Tremelimumab",
      "mappings": [
        {
          "relation": "relatedMatch",
          "coding": {
            "id": "coding:rxcui:2619313",
            "code": "2619313",
            "name": "tremelimumab",
            "system": "RxNorm",
            "systemVersion": "02-Mar-2026",
            "iris": [
              "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=2619313"
            ]
          }
        },
        {
          "relation": "relatedMatch",
          "coding": {
            "id": "coding:omop:741851",
            "code": "741851",
            "name": "tremelimumab",
            "system": "OMOP",
            "systemVersion": "v20260227",
            "iris": [
              "https://athena.ohdsi.org/search-terms/terms/741851"
            ]
          }
        },
        {
          "relation": "relatedMatch",
          "coding": {
            "id": "coding:sctid:2054101000122107",
            "code": "2054101000122107",
            "name": "Tremelimumab",
            "system": "SNOMED",
            "systemVersion": "2025-03-01",
            "iris": [
              "https://browser.ihtsdotools.org/?perspective=full&conceptId1=2054101000122107&edition=MAIN/2025-03-01&release=&languages=en"
            ]
          }
        },
        {
          "relation": "relatedMatch",
          "coding": {
            "id": "coding:omop:1450218",
            "code": "1450218",
            "name": "Tremelimumab",
            "system": "OMOP",
            "systemVersion": "v20260227",
            "iris": [
              "https://athena.ohdsi.org/search-terms/terms/1450218"
            ]
          }
        }
      ],
      "extensions": [
        {
          "name": "therapy_strategy",
          "value": [
            "CTLA-4 inhibition"
          ],
          "description": "Associated therapeutic strategy or mechanism of action of the therapy."
        },
        {
          "name": "therapy_type",
          "value": "Immunotherapy",
          "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
        }
      ],
      "primaryCoding": {
        "id": "coding:ncit:C49085",
        "code": "C49085",
        "name": "Tremelimumab",
        "system": "https://evsexplore.semantics.cancer.gov",
        "systemVersion": "25.01d",
        "iris": [
          "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C49085"
        ]
      }
    }
  ]
}